Sunesis Pharmaceuticals, Inc. Message Board
-
is this in response to cycc's upward climb ???
what's happening to this stock
Sentiment: Buy
-
What will become clearer over the weekend. CYCC has experienced a 28.3% survival rate on an old population for it's SAPA/DAC @ 800 days {pilot arm of Seamless}, With the apparent low toxicity of this regimen, lack of muccocystic lesions, easier administration, and maintenace potential, I doubt there will be much business in the refractory space for SNSS.
Sentiment: Strong Buy
- 1 Reply to lifetolive7
-
Complete remissions have been observed in AML patients treated with vosaroxin in combination with cytarabine.
Sentiment: Strong Buy
-
I own both cycc and snss and am happy when either go up. However, whether they go up or down over a short period doesn't really mean that much unless you day trade. If you believe in the fundamentals of a stock, don't be one of the weak minded fools that buy or sell on temporary fluctuations. Especially, don't listen to the self proclaimed gurus that post here. Always do your own DD and make your own decisions based on that. I plan on making a lot of money on both stocks, but that is my decision for me. Just don't be frightened away by anyone else. My opinion only.
- 1 Reply to truthseekerguy
-
More solid advice, like " It's not a loss unless you sell ". Wrong, it is a loss when you own something worth less than you paid. Selling only makes it a taxable event or historical event.
Live and Learn.
Long CYCC
-
Stocks rise or fall or fall on their own merit.
I have posted that CYCC is the stock to own in this space.
In hindsight, I was right. When investing in the stock market, it all comes down to results, not REASONS.
CYCC headed to $20...... soon.
-